Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with ...

Wellness purchases are now treated more like scientific procurement than regular shopping. Buyers look for data, authenticity ...

(UroToday.com) The 2025 European Society of Medical Oncology (ESMO) Annual Congress held in Berlin, Germany between September ...

Watch parts 1, 2, and 3 of our conversation with Dr Collins.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today announced that it will present new clinical data from its Phase 2 trial of EB613 at ...

Nanopore sensors enable precise protein and peptide analysis, crucial for early disease diagnosis and advancing personalized healthcare solutions.

QuidelOrtho Corporation is broadening its point-of-care diagnostic offerings with the launch of the QUICKVUE Influenza + SARS ...

Umbrella Labs today introduced a research-brief format that will accompany major additions to its investigational catalog, beginning with three widely studied compounds—GW-501516 (Cardarine), RAD-140 ...

SpaceOAR Hydrogel is a polyethylene glycol–based hydrogel designed to create space between the prostate and rectum to reduce ...

Scientists are unraveling the molecular mechanisms of Alzheimer’s to develop earlier diagnoses and breakthrough therapies ...

Elevated plasma concentrations of hsCRP, LDL cholesterol, and lipoprotein(a), individually and in combination, are associated ...